Ensysce Biosciences begins final phase of opioid overdose study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. HOOD
8. QCOM
9. ACN
10. AZN

Go back to Ensysce Biosciences begins final phase of opioid overdose study
(NASDAQ: ENSC) Delayed: 0.47 +0.01 (2.17%)
Previous Close $0.46    52 Week High $ 
Open $0.47    52 Week Low $ 
Day High $0.50    P/E N/A 
Day Low $0.40    EPS $ 
Volume 1,453,364